Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through two segments: Proteomics and Genomics. It provides SomaScan platform that enables researchers to measure thousands of proteins simultaneously, providing deep insights into biological processes and disease mechanism; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system redefines high-throughput genomics by delivering exceptional efficiency, precision, and scalability for qPCR applications. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Standard BioTools Inc.

The latest announcement is out from PMGC Holdings ( ($ELAB) ). On April 6, 2026, NorthStrive Defense Tech LLC, a wholly owned subsidiary of PMGC Ho...

PMGC Explores Advanced Dual-Domain Drone Logistics Technology

Medipharm Labs (Otc) (($TSE:LABS)) has held its Q4 earnings call. Read on for the main highlights of the call. Medipharm Labs’ latest earnings call...

Medipharm Labs Earnings Call Highlights Global Growth Pivot

An update from PMGC Holdings ( ($ELAB) ) is now available. On April 2, 2026, PMGC Holdings Inc. launched NorthStrive Defense Tech LLC, a wholly own...

PMGC Launches NorthStrive Subsidiary Targeting Defense Technology Growth

PMGC Holdings, BullFrog AI Holdings, and 3 E Network Technology Group Ltd. are the 3&nbsp;Penny Stocks&nbsp;to watch on April 2, based on&nbsp;TipR...

3 Penny Stocks to Watch Now, 4/2/26

MediPharm Labs ( ($TSE:LABS) ) just unveiled an update. MediPharm Labs reported 2025 revenue of $45.1 million, up 8% year over year, with internati...

MediPharm Labs Boosts International Medical Cannabis Revenue and Tightens Costs in 2025

PMGC Holdings ( ($ELAB) ) just unveiled an announcement. On March 24, 2026, Northstrive Biosciences Inc., a subsidiary of PMGC Holdings Inc., execu...

PMGC Holdings Updates Northstrive Licensing Milestones with MOA

MediPharm Labs ( ($TSE:LABS) ) has provided an announcement. MediPharm Labs, a specialized pharmaceutical cannabis company focused on precision-bas...

MediPharm Labs Sets March 30 Date for 2025 Results and Investor Call

The latest update is out from Gemina Laboratories Ltd. ( ($TSE:GLAB) ). Gemina Laboratories Ltd., a bio-tools and binding technologies specialist s...

Gemina Labs to Delist from CSE and Appoints New Chairman in Strategic Reset

PMGC Holdings ( ($ELAB) ) has issued an announcement. On March 24, 2026, PMGC Holdings said its subsidiary SVM Machining, Inc. has completed regist...

PMGC Holdings Subsidiary Gains ITAR Defense Compliance Status

An announcement from Mesa Laboratories ( ($MLAB) ) is now available. Mesa Laboratories, Inc. announced on March 9, 2026, that President and Chief E...

Mesa Laboratories CEO Gary Owens Announces Planned Departure

Life Science Reit Plc ( ($GB:LABS) ) just unveiled an announcement. Shareholders of Life Science REIT have overwhelmingly approved a recommended ca...

Life Science REIT Shareholders Back British Land Takeover Scheme

In a report released yesterday, from Shenwan Hongyuan maintained a Buy rating on Zai Lab Ltd, with a price target of HK$19.20. The company’s shares...

Shenwan Hongyuan Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)

With markets navigating volatility due to the rising geopolitical tensions in the Middle East, some stocks are standing out due to their strong per...

3 Best Stocks to Buy This Week, According to Analysts – March 16-20

In a report released yesterday, from KeyBanc maintained a Buy rating on Zai Lab Ltd, with a price target of HK$23.92. Currently, the analyst consen...

KeyBanc Remains a Buy on Zai Lab Ltd (1ZLB)

Zai Lab Ltd ($ZLAB) announced an update on their ongoing clinical study. Zai Lab Ltd. is advancing a late stage study called DLLEVATE that compares...

Zai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung Cancer

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Mesa Laboratories (MLAB – Research Report) and Visha...

Analysts’ Top Technology Picks: Mesa Laboratories (MLAB), Vishay Precision Group (VPG)

PMGC Holdings ( ($ELAB) ) has issued an announcement. PMGC Holdings Inc. said on March 4, 2026, that it will implement a 1-for-6 reverse stock spli...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LAB	$0.93	+0.32%	1.04M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LAB	$0.93	+0.3%	1.04M
3
4
5
6

LAB

LAB

Get Standard BioTools Inc. Data in Excel

Get Standard BioTools Inc. Data in Excel